Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

1.1K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.1K
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

1.0K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.0K
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

870
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
870

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Trabecular surgeries in the management of glaucoma: A review of literature].

Journal francais d'ophtalmologie·2026
Same author

Dry eye disease: food, diet, and nutritional genetics. A narrative review.

Archivos de la Sociedad Espanola de Oftalmologia·2026
Same author

[Imaging modalities for corneal neovascularization].

Journal francais d'ophtalmologie·2026
Same author

[Hereditary transthyretin amyloidosis presenting as vitreous opacities].

Journal francais d'ophtalmologie·2026
Same author

Differences in hospital prenatal care between immigrant and native women in France: a qualitative study within the BiP research on racial implicit bias in perinatal care.

BMC pregnancy and childbirth·2026
Same author

Codon-specific <i>KRAS</i> mutations predict survival in advanced pancreatic cancer.

ESMO gastrointestinal oncology·2026

Related Experiment Video

Updated: Dec 15, 2025

Comparing Objective Conjunctival Hyperemia Grading and the Ocular Surface Disease Index Score in Dry Eye Syndrome During COVID-19
06:29

Comparing Objective Conjunctival Hyperemia Grading and the Ocular Surface Disease Index Score in Dry Eye Syndrome During COVID-19

Published on: May 25, 2022

2.6K

[SARS-CoV-2, COVID-19 and the eye: An update on published data].

A Rousseau1, J-R Fenolland2, M Labetoulle1

  • 1Service d'ophtalmologie, CHU Bicêtre, hôpital Bicêtre, Assistance publique-Hôpitaux de Paris, université Paris-Saclay, réseau OPHTARA : maladies rares en ophtalmologie, Le Kremlin-Bicêtre, France; Département immunologie des maladies virales, auto-immunes, bactériennes et hématologiques. UMR 1184, CEA, Fontenay-Aux-Roses, France.

Journal Francais D'Ophtalmologie
|July 8, 2020
PubMed
Summary

This review covers severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and COVID-19 clinical signs. Ocular involvement in COVID-19 is rare but may pose a contamination risk, necessitating preventive measures for ophthalmologists.

Keywords:
COVID-19ConjonctiviteConjunctivitisLarmesOcular surfaceSARS-CoV-2Surface oculaireTearsTransmission

More Related Videos

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
08:41

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2

Published on: November 5, 2021

3.2K
Author Spotlight: Establishing a Practical and Cost-Effective Protocol for Corneal Sensitivity Testing in Clinical Settings
04:00

Author Spotlight: Establishing a Practical and Cost-Effective Protocol for Corneal Sensitivity Testing in Clinical Settings

Published on: August 2, 2024

2.9K

Related Experiment Videos

Last Updated: Dec 15, 2025

Comparing Objective Conjunctival Hyperemia Grading and the Ocular Surface Disease Index Score in Dry Eye Syndrome During COVID-19
06:29

Comparing Objective Conjunctival Hyperemia Grading and the Ocular Surface Disease Index Score in Dry Eye Syndrome During COVID-19

Published on: May 25, 2022

2.6K
Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
08:41

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2

Published on: November 5, 2021

3.2K
Author Spotlight: Establishing a Practical and Cost-Effective Protocol for Corneal Sensitivity Testing in Clinical Settings
04:00

Author Spotlight: Establishing a Practical and Cost-Effective Protocol for Corneal Sensitivity Testing in Clinical Settings

Published on: August 2, 2024

2.9K

Area of Science:

  • Ophthalmology
  • Infectious Diseases
  • Virology

Background:

  • The COVID-19 pandemic, caused by SARS-CoV-2, has significantly impacted clinical practice.
  • Understanding the virus and its disease manifestations is crucial for healthcare professionals.

Purpose of the Study:

  • To review the SARS-CoV-2 virus and COVID-19 clinical features.
  • To detail the pathophysiology, clinical signs, and challenges of ocular involvement in COVID-19.
  • To discuss preventive strategies for ophthalmologists to mitigate viral transmission.

Main Methods:

  • General review of existing literature.
  • Analysis of SARS-CoV-2 characteristics.
  • Examination of ocular manifestations and transmission risks.
  • Discussion of clinical preventive measures.

Main Results:

  • Ocular involvement in COVID-19 appears rare and not typically severe.
  • The eyes may represent a potential route for SARS-CoV-2 contamination.
  • Specific preventive measures are essential for ophthalmologists' daily practice.

Conclusions:

  • Ophthalmologists require knowledge of SARS-CoV-2 and COVID-19 to adapt their practice.
  • While ocular manifestations are uncommon, they warrant attention due to potential infectivity.
  • Implementing stringent preventive protocols is vital to protect both patients and healthcare providers.